Cited by 204Gastrointestinal motility and disordersPain Mechanisms and TreatmentsUrinary Bladder and Prostate Research

Effect of a second-generation α 2 δ ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome

Open access
Houghton, L A, Fell, C, Whorwell, P J, Jones, I, Sudworth, D P, Gale, J D·2007·Gut

Abstract

Background: Visceral hypersensitivity is an important pathophysiological factor in irritable bowel syndrome (IBS). Pre-clinical studies suggest that the α 2 δ ligand pregabalin reduces both visceral allodynia and hyperalgesia, but is inactive on basal sensitivity. Aim: To assess the effect of pregabalin on the perception of rectal distension in hypersensitive IBS patients. Methods: Twenty-six patients with Rome-II-defined IBS (aged 18–46 years, 7 male) were included in a randomized, double-blind, placebo-controlled, parallel-group study in which they received either 3 weeks oral pregabalin (titrated: 50 mg tid days 1–3, 100 mg tid days 4–7, 150 mg tid days 8–11; fixed 200 mg tid days 12–21 ±4) or placebo control. Rectal sensitivity was assessed using a barostat technique, in which sensory thresholds were determined using the ascending method of limits, followed by tracking both before and after treatment. Only patients with a pain threshold of ⩽28 mmHg were included in the study. Results: Pregabalin significantly increased the sensory thresholds from baseline for first sensation (p = 0.045), desire to defecate (p = 0.008) and pain (p = 0.048) compared with placebo control. In addition, pregabalin significantly increased rectal compliance (p<0.0001), although this appeared to be unrelated to the changes in sensitivity. Despite the occurrence of mild dizziness and somnolence, pregabalin was generally well tolerated. Conclusions: Pregabalin increased distension sensory thresholds to normal levels in IBS patients with rectal hypersensitivity. A concomitant increase in rectal compliance appeared to be unrelated to the reduction in sensitivity. These data suggest that α 2 δ ligands are worthy of further investigation in the treatment of visceral pain disorders, including IBS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gut.2006.110858

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pregabalin improved visceral hypersensitivity in one small trial, and in a recent RCT recruiting 85 patients with IBS, 12 weeks of pregabalin 225 mg twice daily led to significant improvements in global symptoms, abdominal pain, diarrhoea and bloating versus placebo.

    “Pregabalin improved visceral hypersensitivity in one small trial, 227 and in a recent RCT recruiting 85 patients with IBS, 12 weeks of pregabalin 225 mg twice daily led to significant improvements in global symptoms, abdominal pain, diarrhoea and bloating versus placebo.228”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [15]15. Xiao W, Bennett GI. Gabapentin relieves abdominal pains in a rat model of painful peripheral neuropathy [abstract]. Soc Neurosci 1995;21:356.

Cited by

Sorted by citations

Authors
Houghton, L. A., Fell, C., Whorwell, P. J., Jones, I., Sudworth, D. P., & Gale, J. D.
Affiliations
  • University of Manchester (GB)
  • Pfizer (United States) (US)
Corresponding author
Houghton, L A
Venue
Gut
Publisher
BMJ
Published
2007-04-19
Volume
56
Issue
9
Pages
1218-1225
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2117456715
Cited by
204
References
45
Citations by year
2026: 4 · 2025: 11 · 2024: 5 · 2023: 8 · 2022: 5 · 2021: 15 · 2020: 9 · 2019: 7 · 2018: 11 · 2017: 8 · 2016: 8 · 2015: 12 · 2014: 9 · 2013: 9 · 2012: 14
FWCI
13.76
Type
journal article
Language
en
Open access
Locations
  • Gut (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
Pfizer
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
Keywords
pregabalin, irritable bowel syndrome, visceral hypersensitivity, visceral pain, rectal distension, rectal sensory threshold, rectal compliance
MeSH terms
Pregabalin, Administration, Oral, Adolescent, Adult, Analgesics, Double-Blind Method, Female, gamma-Aminobutyric Acid, Humans, Male, Middle Aged, Pain, Pain Measurement, Pressure, Rectum, Sensation, Sensory Thresholds, Pain Threshold, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review